OraSure Technologies, Inc. (OSUR) Earnings Call Analysis

NASDAQ · Healthcare · Medical Instruments & Supplies

16/25

Growth 4 Margin 2 Expansion 5 Platform 2 Financial 3

latest quarter score

Earnings Reports

16
OraSure Technologies (OSUR) Q2 2026: 120bps Margin Expansion Signals Operational Discipline Amid IntelliQuick Delay
August 06, 2026
12
OraSure Technologies (OSUR) Q1 2026: Gross Margin Rises to 43% as Pipeline Launches Approach
May 07, 2026
13
OraSure Technologies (OSUR) Q4 2025: Nearshoring and New Launches Position Core Revenue for Post-Transition Growth
February 26, 2026
9
OraSure Technologies (OSUR) Q3 2025: International Diagnostics Down 20% as Funding Shifts, Sickle Cell Acquisition Targets Growth
November 06, 2025
11
Orchard Technologies (OSUR) Q2 2025: Sample Management Down 22% as Consumer Genetics Pause Weighs on Core Growth
August 06, 2025
12
OraSure Technologies (OSUR) Q1 2025: Diagnostics Revenue Climbs 8% as Funding Shifts Reshape Growth Mix
July 04, 2025

Browse all companies